Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer

NDAQ:APHA - Post by User

Aphria Inc.

Bullboard Posts

Comment by quietobserveron Oct 11, 2019 11:12pm

119 Views

Post# 30224672

RE:hoping for an uptrend soon as CIBC downgraded Aphria

Wasn't this the idiot that said we would get killed last quarter? He's trying again cuz he knows CIBC is still short.

Bestbuy8888 wrote:
APHRIA

CIBC analyst John Zamparo downgraded Aphria to Underperformer from Neutral and lowered his price target for the shares to $6.50 from $12. The stock closed Thursday down 23c to $5.84. The analyst cites concerns about “aggressive” Street estimates, potential asset impairment, a “leadership void and less robust supply contracts” for the downgrade.

While Aphria likely captures a high-single-digit market share, and last month’s partnership with PAX Era was a “meaningful win,” the stock carries more risk than reward at current levels, Zamparo tells investors in a research note.

The analyst believes consensus estimates need to come down to reflect slower industry growth than previously contemplated. He thinks this will pressure the stock.